Serum, plasma and paraffin-embedded tissues as sources of DNA for studying cancer susceptibility genes

Carcinogenesis

Volumn 18, Issue 6, 1997, Pages 1271-1275

  Blömeke, Brunhilde ^a   Bennett, William P ^a   Harris, Curtis C ^a   Shields, Peter G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DNA; FORMALDEHYDE; PARAFFIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER SUSCEPTIBILITY; DNA DETERMINATION; EXON; GENOTYPE; HUMAN; LUNG CANCER; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; TISSUE;

ARYLAMINE N-ACETYLTRANSFERASE; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; DNA; DNA, NEOPLASM; EXONS; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LUNG; LUNG NEOPLASMS; METABOLIC DETOXICATION, DRUG; ONCOGENES; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS;

EID: 0344606379     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.6.1271     Document Type: Article

References (56)

1. Perera, F.P. (1996) Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Natl Cancer Inst., 88, 496-509.
2. Kato, N., Yokosuka, O., Omata, M., Hosoda, K. and Ohto, M. (1990) Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J. Clin. Invest., 86, 1764-1767.
3. Goelz, S.E., Hamilton, S.R. and Vogelstein, B. (1985) Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res Commun., 130, 118-126.
4. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. and Watanabe, J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS, 263, 131-133.
5. Taioli, E., Crofts, F., Trachman, J., Demopoulos, R., Toniolo, P. and Garte, S.J. (1995) A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res., 55, 472-473.
6. Cosma, G., Crofts, F., Currie, D., Wirgin, I., Toniolo, P. and Garte, S.J. (1993) Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol. Biomarkers Prev., 2, 53-57.
7. Nakachi, K., Imai, K., Hayashi, S., Watanabe, J. and Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.
8. Hayashi, S., Watanabe, J., Nakachi, K. and Kawajiri, K. (1991) Genetic linkage of lung cancer-associated Mspl polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem. (Tokyo), 110, 407-411.
9. Crofts, F., Taioli, E., Trachman, J., Cosma, G.N., Currie, D., Toniolo, P. and Garte, S.J. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
10. Kawajiri, K., Watanabe, J., Gotoh, O. and Tagashira, Y. (1986) Structure and drug inducibility of the human cytochrome P-450c gene. Eur. J. Biochem., 159, 219-225.
11. Hayashi, S., Watanabe, J. and Kawajiri, K. (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. (Tokyo), 110, 559-565.
12. Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I., Ohmachi, T., Wakui, A., Kanamaru, R. and Watanabe, M. (1991) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res., 82, 254-256.
13. Kato, S., Shields, P.G., Caporaso, N.E., Hoover, R.N., Trump, B.F., Sugimura, H., Weston, A. and Harris, C.C. (1992) Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res., 52, 6712-6715.
14. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A. and Vainio, H. (1993) The human CYP2E1 gene and lung cancer: DraI and Rsal restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis, 14, 85-88.
15. Kato, S., Shields, P.G., Caporaso, N.E., Sugimura, H., Trivers, G.E., Tucker, M.A., Trump, B.F., Weston, A. and Harris, C.C. (1994) Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol. Biomarkers Prev., 3, 515-518.
16. Kato, S., Bowman, E.D., Harrington, A.M., Blomeke, B. and Shields, P.G. (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl Cancer Inst., 87, 902-907.
17. Umeno, M., McBride, O.W., Yang, C.S., Gelboin, H.V. and Gonzalez, F.J. (1988) Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry, 27, 9006-9013.
18. Seidegard, J., Pero, R.W., Markowitz, M.M., Roush, G., Miller, D.G. and Beattie, E.J. (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
19. Heckbert, S.R., Weiss, N.S., Hornung, S.K., Eaton, D.L. and Motulsky, A.G. (1992) Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl Cancer Inst., 84, 414-422
20. Brockmoller, J., Kerb, R., Drakoulis, N., Nitz, M. and Roots, I. (1993) Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res., 53, 1004-1011.
21. Nazar-Stewart, V., Motulsky, A.G., Eaton, D.L., White, E., Hornung, S.K., Leng, Z.T., Stapleton, P. and Weiss, N.S. (1993) The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53, 2313-2318.
22. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S. and Vainio, H. (1993) The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis, 14, 1479-1481.
23. Nakachi, K., Imai, K., Hayashi, S. and Kawajiri, K. (1993) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999.
24. Hayashi, S.I., Watanabe, J. and Kawajiri, K. (1992) High susceptibility to lung cancer in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res., 83, 866-870.
25. McWilliams, J.E., Sanderson, B.J., Harris, E.L., Richert-Boe, K.E. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer, Epidemiol., Biomarkers Prev., 4, 589-594.
26. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
27. Strange, R.C., Matharoo, B., Faulder, G.C., Jones, P., Cotton, W., Elder, J.B. and Deakin, M. (1991) The human glutathione S-transferases: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis, 12, 25-28.
28. Pearson, W.R., Vorachek, W.R., Xu, S.J., Berger, R., Hart, I., Vannais, D. and Patterson, D. (1993) Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am. J. Hum. Genet., 53, 220-233.
29. Blum, M., Demierre, A., Grant, D.M., Heim, M. and Meyer, U.A. (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl Acad. Sci. USA, 88, 5237-5241.
30. Deguchi, T., Mashimo, M. and Suzuki, T. (1990) Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem., 265, 12757-12760.
31. Vatsis, K.P., Martell, K.J. and Weber, W.W. (1991) Diverse point mutations in the human gene for polymorphic arylamine N-acetyltransferase in human liver. Proc. Natl Acad. Sci USA, 88, 6333-6337.
32. Bell, D.A., Taylor, J.A., Butler, M.A., Stephens, E.A., Wiest, J., Brubaker, L.H., Kadlubar, F.F. and Lucier, G.W. (1993) Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis, 14, 1689-1692.
33. Hickman, D., Risch, A., Camilleri, J.P. and Sim, E. (1992) Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics, 1, 217-226.
34. Lin, H.J., Han, C.Y., Lin, B.K. and Hardy, S. (1994) Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics, 4, 125-134.
35. Hein, D.W. (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948, 37-66.
36. Lang, N.P., Butler, M.A., Massengill, J., Lawson, M., Stotts, R.C., Hauer-Jensen, M. and Kadlubar, F.F. (1994) Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev., 3, 675-682.
37. Wohlleb, J.C., Hunter, C.F., Blass, B., Kadlubar, F.F., Chu, D.Z. and Lang, N.P. (1990) Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int. J. Cancer, 46, 22-30.
38. Ilett, K.F., David, B.M., Detchon, P., Castleden, W.M. and Kwa, R. (1987) Acetylation phenotype in colorectal carcinoma. Cancer Res., 47, 1466-1469.
39. Kadlubar, F.F., Butler, M.A., Kaderlik, K.R., Chou, H.C. and Lang, N.P. (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human Carcinogenesis. Environ. Hlth Perspect., 98, 69-74.
40. Vatsis, K.P., Weber, W.W., Bell, D.A., et al. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-17.
41. Blum, M., Grant, D.M., McBride, W., Heim, M. and Meyer, U.A. (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell. Biol., 9, 193-203.
42. Greer, C.E., Wheeler, C.M. and Manos, M.M. (1994) Sample preparation and PCR amplification from paraffin-embedded tissues. PCR. Methods Appl., 3, S113-122.
43. Rothman, N., Stewart, W.F., Caporaso, N.E. and Hayes, R.B. (1993) Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol. Biomarkers Prev., 2, 299-303.
44. Schubert, E.L., Bischoff, F.Z. and Whitaker, L.L. (1993) Pleasles for p53 gene analysis. Hum. Mutat., 2, 123-126.
45. Chen, B.F. and Clejan, S. (1993) Rapid preparation of tissue DNA from paraffin-embedded blocks and analysis by polymerase chain reaction. J. Histochem. Cytochem., 41, 765-768.
46. Shibata, D.K., Amheim, N. and Martin, W.J. (1988) Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J. Exp. Med., 167, 225-230.
47. Slebos, R.J., Boerrigter, L., Evers, S.G., Wisman, P., Mooi, W.J. and Bodenhuis, S. (1992) A rapid and simple procedure for the routine detection of ras point mutation in formalin-fixed, paraffin-embedded tissues. Diagn. Mol. Pathol., 1, 136-141.
48. Lau, J.Y., Mizokami, M., Kolberg, J.A., et al. (1995) Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J. Infect. Dis., 171, 281-289.
49. Chan, C.Y., Lee, S.D., Hwang, S.J., Lu, R.H., Lu, C.L. and Lo, K.J. (1995) Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C. J. Infect. Dis., 171, 443-446.
50. Stein, E.L., Santoso, S., Behrens, G., Mueller-Eckhardt, C. and Bux, J. (1995) Genotyping of the granulocyte-specific NA antigens from small quantities of blood or serum. Tiss. Antigens, 45, 69-72.
51. Martin, M., Carrington, M. and Mann, D. (1992) A method for using serum or plasma as a source of DNA for HLA typing. Hum. Immunol., 33, 108-113.
52. Secchiero, P., Carrigan, D.R., Asano, Y., Benedetti, L., Crowley, R.W., Komaroff, A.L., Gallo, R.C. and Lusso, P. (1995) Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J. Infect. Dis., 171, 273-280.
53. Sorenson, G.D., Pribish, D.M., Valone, F.H., Memoli, V.A., Bzik, D.J. and Yao, S.L. (1994) Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomarkers Prev., 3, 67-71.
54. Cantlay, A.M., Smith, C.A., Wallace, W.A., Yap, P.L., Lamb, D. and Harrison, D.J. (1994) Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax, 49, 1010-1014.
55. Lin, H.J., Han, C.Y., Bernstein, D.A., Hsiao, W., Lin, B.K. and Hardy, S. (1994) Et 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis, 15, 1077-1081.
56. Seidegard, J., Vorachek, W.R., Pero, R.W. and Pearson, W.R. (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl Acad. Sci USA, 85, 7293-7297.